ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester in hyperuricemic mice through inhibiting XOD and down-regulating URAT1

Yong, Tianqiao; Liang, Danling; Xiao, Chun; Huang, Longhua; Chen, Shaodan; Xie, Yizhen; Gao, Xiong; Wu, Qingping*; Hu, Huiping; Li, Xiangmin; Liu, Yuancao; Cai, Manjun广东医学院
Biomedicine and Pharmacotherapy2022-9DOI: 10.1016/j.biopha.2022.113303
2被引9阅读
引用收藏
分享

摘要

In this paper, we reported the hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester (DAE), a component of Ganoderma applanatum, in hyperuricemic mice through inhibiting XOD and down-regulating URAT1. Computationally, DAE showed a high similarity to allopurinol and depicted a high affinity in docking to XOD. In vitro, DAE exhibited an inhibitory effect against XOD. Importantly, DAE demonstrated a remarkable hypouricemic effect, decreasing serum uric acids (SUAs) of hyperuricemic mice (407 +/- 31 mu mol/L) to 195 +/- 23, 145 +/- 33 and 134 +/- 16 mu mol/L (P < 0.01) at the doses of 20, 40, and 80 mg/kg with a dose-dependent manner and showing efficacies at 54-68 %, which were close to the efficacies of allopurinol (61 %) and benzbromarone (57 %). DAE depicted higher and negatively dose-independent urinary uric acids in comparison with that of the hyperuricemic control, implying DAE exerted an uricosuric effect and also a reduction effect on uric acid production. Unlike toxic allopurinol and benzbromarone, no general toxicity on body weights and no negative influence on liver, kidney, spleen and thymus were observed for DAE. Mechanistically, DAE inhibited XOD activities in vivo. Moreover, DAE up-regulated OAT1 and down-regulated GLUT9, URAT1 and CNT2. Overall, DAE may present a hypouricemic effect through inhibiting XOD and up-regulating OAT1 and down-regulating GLUT9, URAT1 and CNT2. This work provided novel insights into the hypouricemic effect of DAE and G. applanatum.

学科与关键词

关键词
Hyperuricemia4-dihydroxybenzoic acid methyl esterMolecular dockingXanthine oxidaseUric acid transporter 1Organic anion transporter 1Glucose transporter 9Concentrated nucleoside transporter 2
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2022-09
卷期
第 153 卷
页码
113303
DOI
10.1016/j.biopha.2022.113303
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
National Natural Science Foundation of China (China) [31901696, 81803393]; Natural Science Foundation of Guangdong (China) [2022A1515011066, 2021A1515010960]; Science and Technology Program of Guangzhou (China) [202002030225, 202102021281]; Science and Technology Special Project of Guangdong Province (China) [210909154531306]; Guangdong Province Sail Plan (China) [2017YT05S115]; GDAS' Project of Science and Technology Development (China) [2020GDASYL-20200103020]

作者

  • Y

    Yong, Tianqiao (第一作者)

  • L

    Liang, Danling

    guangdong med univ

查看全部 12 位作者收起作者
  • X

    Xiao, Chun

  • H

    Huang, Longhua

  • C

    Chen, Shaodan

  • X

    Xie, Yizhen

  • G

    Gao, Xiong

  • W

    Wu, Qingping (通讯)

  • H

    Hu, Huiping

  • L

    Li, Xiangmin

  • L

    Liu, Yuancao

  • C

    Cai, Manjun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417